Editorial Policy

The site is built around cautious interpretation of vitamin B12 and cardiovascular risk topics. It aims to separate biologic plausibility from proven clinical outcome benefit and to avoid exaggerated supplement claims.

Where the evidence is mixed, the site prefers clear explanation of uncertainty rather than overstated certainty.

Priority is given to high-quality source types such as major medical journals, systematic reviews, randomized trial summaries, clinical reviews, recognized regulators, and government or institutional health resources.

Authority references may include sources such as NIH Office of Dietary Supplements, PubMed-indexed studies, BMJ journals, Frontiers reviews, and formal regulatory updates when they are relevant to the claim being made.

Educational pages are written in plain English for readers who want a practical understanding of what the literature supports. Pages are not written as treatment directives or as a substitute for individualized care.

Mechanism pages, supplement pages, and keyword blog articles are intended to complement one another through internal linking and topic depth.

Content may be updated when stronger studies, new guideline shifts, or materially important regulatory statements become available.

If a claim becomes outdated or overstated, the site should revise the page so that the public-facing interpretation stays aligned with current evidence.